This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Albert Shieh of UCLA, is devoted to Bone Disorders. Articles in this outstanding issue include: Role of Osteocyte in Bone and Non-Bone Disease; Bone-Fat Interaction; Imaging Beyond DXA; Vitamin D in African-Americans; Pre-Menopausal Osteoporosis; Combined Pharmacologic Therapy in Osteoporosis; Drug-Related Adverse Events in Osteoporosis; Novel Therapies for Osteoporosis; Diabetes and Bone Disease; Bariatric Surgery and Bone Metabolism; Hyperparathyroidism and Bone Microarchitecture; FGF-23 Mediated Bone Disease; and Endothelin-Related Bone Disorder.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xvii 9. Erratum - p. xix 10. The Role of the Osteocyte in Bone and Nonbone Disease - p. 1 11. Fibroblast Growth Factor 23–Mediated Bone Disease - p. 19 12. Bone–Fat Interaction - p. 41 13. Endothelin Signaling in Bone - p. 51 14. Diabetes and Bone Disease - p. 63 15. Primary Hyperparathyroidism: Effects on Bone Health - p. 87 16. The Effects of Bariatric Surgery on Bone Metabolism - p. 105 17. Premenopausal Osteoporosis - p. 117 18. Assessing Vitamin D Status in African Americans and the Influence of Vitamin D on Skeletal Health Parameters - p. 135 19. Trabecular Bone Score: A New DXA–Derived Measurement for Fracture Risk Assessment - p. 153 20. Drug-Related Adverse Events of Osteoporosis Therapy - p. 181 21. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis - p. 193 22. Novel Therapies for Postmenopausal Osteoporosis - p. 207 23. Index - p. 221
No hay muestra disponible
No hay ficha técnica disponible
This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Albert Shieh of UCLA, is devoted to Bone Disorders. Articles in this outstanding issue include: Role of Osteocyte in Bone and Non-Bone Disease; Bone-Fat Interaction; Imaging Beyond DXA; Vitamin D in African-Americans; Pre-Menopausal Osteoporosis; Combined Pharmacologic Therapy in Osteoporosis; Drug-Related Adverse Events in Osteoporosis; Novel Therapies for Osteoporosis; Diabetes and Bone Disease; Bariatric Surgery and Bone Metabolism; Hyperparathyroidism and Bone Microarchitecture; FGF-23 Mediated Bone Disease; and Endothelin-Related Bone Disorder.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xvii 9. Erratum - p. xix 10. The Role of the Osteocyte in Bone and Nonbone Disease - p. 1 11. Fibroblast Growth Factor 23–Mediated Bone Disease - p. 19 12. Bone–Fat Interaction - p. 41 13. Endothelin Signaling in Bone - p. 51 14. Diabetes and Bone Disease - p. 63 15. Primary Hyperparathyroidism: Effects on Bone Health - p. 87 16. The Effects of Bariatric Surgery on Bone Metabolism - p. 105 17. Premenopausal Osteoporosis - p. 117 18. Assessing Vitamin D Status in African Americans and the Influence of Vitamin D on Skeletal Health Parameters - p. 135 19. Trabecular Bone Score: A New DXA–Derived Measurement for Fracture Risk Assessment - p. 153 20. Drug-Related Adverse Events of Osteoporosis Therapy - p. 181 21. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis - p. 193 22. Novel Therapies for Postmenopausal Osteoporosis - p. 207 23. Index - p. 221
No hay muestra disponible
No hay ficha técnica disponible
